Next-generation sequencing has driven major advances in our understanding of monogenic cause of elevated LDL-C and premature CHD, focussing on the three proven FH-causing genes (LDLR, APOB and PCSK9). The gene discussed is LDLR; the disease is familial hyperaldosteronism.